Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Apr;26(4):592-598.
doi: 10.1038/s41431-018-0097-3. Epub 2018 Feb 15.

Biallelic inactivating variants in the GTPBP2 gene cause a neurodevelopmental disorder with severe intellectual disability

Affiliations
Case Reports

Biallelic inactivating variants in the GTPBP2 gene cause a neurodevelopmental disorder with severe intellectual disability

Aida M Bertoli-Avella et al. Eur J Hum Genet. 2018 Apr.

Abstract

Congenital neurological disorders are genetically highly heterogeneous. Rare forms of hereditary neurological disorders are still difficult to be adequately diagnosed. Pertinent studies, especially when reporting only single families, need independent confirmation. We present three unrelated families in which whole-exome sequencing identified the homozygous non-sense variants c.430[C>T];[C>T] p.(Arg144*), c.1219[C>T];[C>T] p.(Gln407*) and c.1408[C>T];[C>T] p.(Arg470*) in GTPBP2. Their clinical presentations include early onset and apparently non-progressive motor and cognitive impairment, and thereby overlap with findings in a recently described family harbouring a homozygous GTPBP2 splice site variant. Notable differences include structural brain abnormalities (e.g., agenesis of the corpus callosum, exclusive to our patients), and evidence for brain iron accumulation (exclusive to the previously described family). This report confirms pathogenicity of biallelic GTPBP2 inactivation and broadens the phenotypic spectrum. It also underlines that a potential involvement of brain iron accumulation needs clarification. Further patients will have to be identified and characterised in order to fully define the core features of GTPBP2-associated neurological disorder, but future approaches to molecular diagnosis of neurodevelopmental disorders should implement GTPBP2.

PubMed Disclaimer

Conflict of interest statement

A.M.B.-A., Z.Y., A.M., M.C., O.P., P.B., and A.R. are employees of Centogene A.G.; J.G.A. and O.B. are former employees of the company.

Figures

Fig. 1
Fig. 1
Three families carrying homozygous GTPBP2 (NM_019096.4) non-sense variants. Stars denote individuals analysed by WES. Allelic status for the variants in question is provided below individual symbols in the pedigrees. Sequence traces confirming the primary WES data are shown to the right; the predicted consequences at protein are indicated below the traces. a Family 1 and variant c.1219C>T. b Family 2 and variant c.1408C>T. Several third and fourth-degree relatives of the index case are affected by a reportedly similar disease (grey symbols). Dotted relationship lines indicate that consanguinity is likely. c Family 3 and variant c.430C>T. d Magnet resonance imaging of the index patient III-3 from family 1 at age 6 years. On the left: sagittal T1-weighted spin-echo image discloses a thin corpus callosum (arrowhead) with absent rostrum (arrow), hypoplasia of cerebellar vermis (stippled arrow) and presence of mega cisterna magna (star). On the right: axial T2*-weighted fast field-echo image (section through upper tectum) does not reveal evidence for specific hypointensities in the globus pallidus bilaterally (arrows) or in the substantia nigra (arrow heads). e Index patient from family 3 at age 2 years. Note dysmorphic features and sparse hair

References

    1. Parikshak NN, Gandal MJ, Geschwind DH. Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders. Nat Rev Genet. 2015;16:441–58. doi: 10.1038/nrg3934. - DOI - PMC - PubMed
    1. Liu YT, Lee YC, Soong BW. What we have learned from the next-generation sequencing: contributions to the genetic diagnoses and understanding of pathomechanisms of neurodegenerative diseases. J Neurogenet. 2015;29:103–12. doi: 10.3109/01677063.2015.1060972. - DOI - PubMed
    1. Matalonga L, Bravo M, Serra-Peinado C, et al. Mutations in TRAPPC11 are associated with a congenital disorder of glycosylation. Hum Mut. 2017;38:148–51. doi: 10.1002/humu.23145. - DOI - PubMed
    1. Novarino G, Fenstermaker AG, Zaki MS, et al. Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders. Science. 2014;343:506–11. doi: 10.1126/science.1247363. - DOI - PMC - PubMed
    1. Jaberi E, Rohani M, Shahidi GA, et al. Identification of mutation in GTPBP2 in patients of a family with neurodegeneration accompanied by iron deposition in the brain. Neurobiol Aging. 2016;38:216 e211–216 e218. doi: 10.1016/j.neurobiolaging.2015.10.034. - DOI - PubMed

Publication types

Substances